Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON PROPERTIES LTD PARTNERSHIPN/A · Entity 41445 | Director | May 31, 2018 | June 04, 2018 |
| BXP, Inc.BXP · Entity 3450 | Director | May 31, 2018 | June 04, 2018 |
| LOEWS CORPL · Entity 3231 | Director | May 08, 2019 | May 09, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON PROPERTIES LTD PARTNERSHIP
Report date May 31, 2018 · Filed June 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| LTIP UnitsSEC Table II · derivative / convertible security | Direct | 7,479 |
Reported balance
After 2018-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-31 · Grant · Acquired 1,047 · Balance 7,479 F1: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F2: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of Boston Properties, Inc.'s 2019 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date.
F2: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of Boston Properties, Inc.'s 2019 annual meeting of stockholders.
BXP, Inc.
Report date May 31, 2018 · Filed June 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| LTIP UnitsSEC Table II · derivative / convertible security | Direct | 7,479 |
Reported balance
After 2018-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-31 · Grant · Acquired 1,047 · Balance 7,479 F1: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F2: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date.
F2: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders.
LOEWS CORP
Report date May 08, 2019 · Filed May 09, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,636.6 |
Reported balance
After 2019-05-08 transaction · row 1
1 source rowRow 1 · 2019-05-08 · Exercise / conversion · Acquired 1,959 · Balance 6,636.6 F1: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-08 · Exercise / conversion · Disposed 1,959 · Balance 0 F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs").
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BRAINSTORM CELL THERAPEUTICS INC.
Report date July 24, 2026 · Filed July 28, 2026
Section 16 reporting ended · disclosed 2026-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 343,777 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 100,000 · Balance 343,777 F1: Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 28, 2026 21:01 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-087588 · tm2621485-2_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,777 F1 · shares: Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date. Read SEC document |
| February 26, 2026 Filed May 29, 2026 21:01 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-068336 · tm2615354-2_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,777 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:36 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000894 · tm251864-9_4seq1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,777 F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date. F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:30 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001104659-22-044247 · tm2212273-1_4seq1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-04-06 F1 · derivative.exercise_date: Pursuant to the Company's Second Amended and Restated Director Compensation Plan, as amended, this option shall vest and become exercisable in 12 consecutive, equal monthly installments commencing on May 6, 2022 until fully vested and exercisable on the 12 month anniversary of April 6, 2022, provided that the Reporting Person remains a member of the Board of Directors of the Issuer on each vesting date. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:02 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001104659-21-148749 · tm2135032-4_4.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-12-10 F1 · derivative.exercise_date: Pursuant to the Company's Second Amended and Restated Director Compensation Plan, as amended, option vested and became exercisable in 12 consecutive, equal monthly installments commencing on May 6, 2021 until fully vested and exercisable on the 12 month anniversary of April 6, 2021, provided that the Reporting Person remained a member of the Board of Directors of the Issuer on each vesting date. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 22:14 UTC | BRAINSTORM CELL THERAPEUTICS INC. BCLI · Entity 7869 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001104659-20-044270 · tm2014134d4_4.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-04-06 F1 · derivative.exercise_date: Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on the one month anniversary of the date of grant until fully vested and exercisable on the 12 month anniversary of the date of grant, provided that the Reporting Person remains a member of the Board of Directors of the Issuer on each vesting date. Read SEC document |
| May 08, 2019 Filed May 9, 2019 13:29 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010201 · doc1.xml · derivative · entry 2 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,959 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F3 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with 7 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 08, 2019 Filed May 9, 2019 13:29 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010201 · doc1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,636.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:30 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-007911 · doc1.xml · derivative · entry 2 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959.6 Underlying: Common Stock · 2.7 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 14:51 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-002502 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,956.9 Underlying: Common Stock · 2.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:23 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028406 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954.5 Underlying: Common Stock · 2.5 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| June 12, 2018 Filed Dec 13, 2018 21:30 UTC | LOEWS CORP L · Entity 3231 | OtherCommon Stock | 2.6 | $50.02 | $130.05 |
DisclosureSEC source: 0001567619-18-007911 · doc1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,677.6 F1 · kind: The Reporting Person's purchase of 2.6 shares of Common Stock reported herein resulted from an erroneous broker enrollment of the Reporting Person in an automatic dividend reinvestment program. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 17:02 UTC | BOSTON PROPERTIES LTD PARTNERSHIP N/A · Entity 41445 | GrantLTIP Units · Derivative | 1,047 | $0.25 | $261.75 |
DisclosureSEC source: 0001246991-18-000109 · wf-form4_152813170641737.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,479 Underlying: Common OP Units · 1,047 shares Expires not disclosed F1 · security: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F1 · derivative.exercise_price: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F1 · derivative.exercise_date: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F2 · derivative.exercise_date: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of Boston Properties, Inc.'s 2019 annual meeting of stockholders. F1 · derivative.expiration_date: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 16:57 UTC | BXP, Inc. BXP · Entity 3450 | GrantLTIP Units · Derivative | 1,047 | $0.25 | $261.75 |
DisclosureSEC source: 0001246991-18-000102 · wf-form4_152813138323258.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,479 Underlying: Common Stock, par value $0.01 · 1,047 shares Expires not disclosed F1 · security: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F1 · derivative.exercise_price: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F1 · derivative.exercise_date: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F2 · derivative.exercise_date: The 1,047 LTIP Units will vest on the earlier of (i) May 31, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders. F1 · derivative.expiration_date: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. Read SEC document |
| May 09, 2018 Filed May 9, 2018 20:28 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 2,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022506 · doc1.xml · derivative · entry 3 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,141 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2017, the Reporting Person was granted 2,131 RSUs, which, together with 10 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2017, the Reporting Person was granted 2,131 RSUs, which, together with 10 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the such RSUs, vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 09, 2018 Filed May 9, 2018 20:28 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022506 · doc1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:28 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022506 · doc1.xml · derivative · entry 2 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952 Underlying: Common Stock · 1,952 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 8, 2019, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 8, 2019, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:26 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-013641 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,141.9 Underlying: Common Stock · 2.6 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 14:48 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-046142 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139.3 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 18:06 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-035477 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,136.6 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 17:13 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-025106 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,133.8 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 19:03 UTC | BOSTON PROPERTIES LTD PARTNERSHIP N/A · Entity 41445 | GrantLTIP Units · Derivative | 1,050 | $0.25 | $262.50 |
DisclosureSEC source: 0001246991-17-000142 · wf-form4_149634378110566.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,432 Underlying: Common OP Units · 1,050 shares Expires not disclosed F1 · security: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F1 · derivative.exercise_price: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F1 · derivative.exercise_date: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. F2 · derivative.exercise_date: The 1,050 LTIP Units will vest on the earlier of (i) May 31, 2018 and (ii) the date of Boston Properties, Inc.'s 2018 annual meeting of stockholders. F1 · derivative.expiration_date: Issued pursuant to Boston Properties, Inc.'s ("BPI"), the Issuer's general partner, equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in the Issuer ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be redeemed, at the election of the holder, for cash equal to the then fair market value of a share of common stock of BPI except that BPI may, at its election, acquire each Common OP Unit so presented for redemption for one share of common stock of BPI. LTIP Units have no expiration date. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 19:00 UTC | BXP, Inc. BXP · Entity 3450 | GrantLTIP Units · Derivative | 1,050 | $0.25 | $262.50 |
DisclosureSEC source: 0001246991-17-000134 · wf-form4_149634363036248.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,432 Underlying: Common Stock, par value $0.01 · 1,050 shares Expires not disclosed F1 · security: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F1 · derivative.exercise_price: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F1 · derivative.exercise_date: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. F2 · derivative.exercise_date: The 1,050 LTIP Units will vest on the earlier of (i) May 31, 2018 and (ii) the date of the Issuer's 2018 annual meeting of stockholders. F1 · derivative.expiration_date: Represents units of limited partnership interest in Boston Properties Limited Partnership ("BPLP"), of which the Issuer is the general partner, issued pursuant to the Issuer's equity based incentive programs. Conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, each LTIP Unit may be converted, at the election of the holder, into a common unit of limited partnership interest in BPLP ("Common OP Unit"). Each Common OP Unit acquired upon conversion of an LTIP Unit may be presented for redemption, at the election of the holder, for cash equal to the then fair market value of a share of the Issuer's Common Stock, except that the Issuer may, at its election, acquire each Common OP Unit so presented for one share of Common Stock. LTIP Units have no expiration date. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:10 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 2,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019582 · doc1.xml · derivative · entry 3 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. F4 · derivative.exercise_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. F4 · derivative.expiration_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:10 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-019582 · doc1.xml · nonDerivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. Read SEC document |
| May 09, 2017 Filed May 11, 2017 17:10 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019582 · doc1.xml · derivative · entry 2 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,131 Underlying: Common Stock · 2,131 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 19:55 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-012095 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534.5 Underlying: Common Stock · 3.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:09 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.3 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089808 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,531.1 Underlying: Common Stock · 3.3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 17:13 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-079754 · doc1.xml · derivative · entry 1 FRENKEL JACOB A · CIK 0001237418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,527.8 Underlying: Common Stock · 3.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.